Patient-Reported Treatment Satisfaction with Dabigatran versus Warfarin in Patients with Non-Valvular Atrial

Yan-Ping Geng1,2, Di-Hui Lan3, Nian Liu1

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.

Thrombosis and Haemostasis
|September 21, 2018
PubMed

Insights

In China, dabigatran for non-valvular atrial fibrillation (NVAF) patients showed no improved satisfaction over warfarin. Higher costs and discontinuation rates were observed with dabigatran, impacting treatment adherence.

Area of Science:

  • Cardiology
  • Pharmacology
  • Health Economics

Background:

  • Patient satisfaction with anticoagulant therapy is crucial for adherence and outcomes in atrial fibrillation.
  • Warfarin has known disadvantages, leading to the exploration of novel oral anticoagulants like dabigatran.

Purpose of the Study:

  • To compare patient-reported treatment satisfaction between dabigatran and warfarin in Chinese non-valvular atrial fibrillation (NVAF) patients.
  • To assess the impact of economic factors and discontinuation rates on treatment choice.

Main Methods:

  • Patient satisfaction was measured using the Anti-Clot Treatment Scale (ACTS) questionnaire.
  • Propensity score matching was used to create comparable groups of 182 dabigatran and warfarin users.
  • Logistic regression analysis identified factors associated with treatment non-persistence.

Main Results:

  • Global ACTS Burdens and Benefits scores were similar between dabigatran and warfarin groups.
  • Dabigatran was significantly more expensive than warfarin due to lack of insurance coverage.
  • Dabigatran had a higher discontinuation rate (33.5% vs. 19.2%) and greater odds of non-persistence.

Conclusions:

  • Dabigatran therapy in Chinese NVAF patients did not improve satisfaction compared to warfarin.
  • Increased economic burden associated with dabigatran led to higher discontinuation rates.
  • Warfarin remains a viable option, considering cost-effectiveness and adherence in this population.
Abstract

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Data Reporting and Recording01:24

Data Reporting and Recording

Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.5K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
274
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
265
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
238